NCT01632059View on ClinicalTrials.gov

Examination of ADMA Serum Level and DDAH II

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2017

Conditions
Septic ShockSepsis
Trial Locations (1)

20246

Universitätskrankenhaus Hamburg Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT01632059 - Examination of ADMA Serum Level and DDAH II | Biotech Hunter | Biotech Hunter